Products

myPip

AI-nativeMCP

Vibe Code a Video Game Build, Play, Monetize

mypip.dev DiscordSoftware Development / Game Development

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Tanis Lash
No social account linked
Launched
23d ago
2026-10-24 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@mypipdev
  • Launched on Product HuntLaunch

    Vibe code, publish, and monetize games with AI

    Oct 24 · 23d agoLaunch page

    At the time: <5K visits/moVisits: next 1 mo +652%

MCP Server & Agent Ecosystem

GitHub · MCP / Skill

Agent, MCP & Developer Integration

MCP Server
Ecosystem & integrations:
ChatGPTClaude
Browse all MCP Server products →

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct29%
  • Organic Search22%
  • Referrals12%
  • Display Ads11%
  • Other26%

Countries

No data yet

Search

Domain authority —Domain registered Unknown

KeywordMonthly volume
mypip990

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-07 · Source page

Pages & changes

Tracked since 2026-10-24

Key pages

Weekly snapshots
Home
mypip.dev/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does myPip get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is myPip and what platforms does it support?
myPip is catalogued under Game Development: Vibe Code a Video Game Build, Play, Monetize. Supported platforms: MCP Server.

Related products in this category

Software Development / Game Development

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.